Legend Biotech Corp. (LEGN)
Legend Biotech Market Cap : 3.102B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 3.102B |
| November 13, 2026 | 3.394B |
| November 12, 2026 | 3.596B |
| November 11, 2026 | 3.790B |
| November 10, 2026 | 3.959B |
| November 09, 2026 | 4.712B |
| November 06, 2026 | 4.539B |
| November 05, 2026 | 4.372B |
| November 04, 2026 | 4.412B |
| November 03, 2026 | 4.162B |
| November 02, 2026 | 4.089B |
| October 30, 2026 | 4.191B |
| October 29, 2026 | 4.321B |
| October 28, 2026 | 4.366B |
| October 27, 2026 | 4.178B |
| October 26, 2026 | 3.951B |
| October 23, 2026 | 3.734B |
| October 22, 2026 | 3.662B |
| October 21, 2026 | 3.610B |
| October 20, 2026 | 3.684B |
| October 19, 2026 | 3.614B |
| October 16, 2026 | 3.581B |
| October 15, 2026 | 3.837B |
| October 14, 2026 | 3.689B |
| October 13, 2026 | 3.465B |
| Date | Value |
|---|---|
| October 12, 2026 | 3.449B |
| October 09, 2026 | 3.608B |
| October 08, 2026 | 3.625B |
| October 07, 2026 | 3.705B |
| October 06, 2026 | 3.627B |
| October 05, 2026 | 3.638B |
| October 02, 2026 | 3.598B |
| October 01, 2026 | 3.744B |
| September 30, 2026 | 3.854B |
| September 29, 2026 | 3.647B |
| September 28, 2026 | 3.608B |
| September 25, 2026 | 3.703B |
| September 24, 2026 | 3.693B |
| September 23, 2026 | 3.575B |
| September 22, 2026 | 3.612B |
| September 21, 2026 | 3.591B |
| September 18, 2026 | 3.412B |
| September 17, 2026 | 3.406B |
| September 16, 2026 | 3.294B |
| September 15, 2026 | 3.424B |
| September 14, 2026 | 3.591B |
| September 11, 2026 | 3.612B |
| September 10, 2026 | 3.718B |
| September 09, 2026 | 3.858B |
| September 08, 2026 | 3.970B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 207.97B |
| Ionis Pharmaceuticals, Inc. | 4.661B |
| Cellectar Biosciences, Inc. | 10.14M |
| ACADIA Pharmaceuticals, Inc. | 3.226B |
| Alnylam Pharmaceuticals, Inc. | 21.38B |
Market Cap Related Metrics
| PS Ratio | 2.242 |
| Price to Book Value | 2.437 |
| Price | 15.99 |
| Earnings Yield | -0.19% |
| Operating PE Ratio | 80.45 |